4 Electrolyte Imbalances

How to Think About Electrolyte Imbalances

Electrolytes support nerve signaling, muscle contraction, cardiac conduction, fluid balance, and bone metabolism. The kidneys, hormones, and shifts between extracellular fluid and cells regulate their concentrations. A serum result does not always indicate the body’s total stores: a change in water balance or movement between compartments can alter the measured concentration.

Approximate adult reference ranges are sodium $135\text{–}145\ \mathrm{mEq/L}$, potassium $3.5\text{–}5.0\ \mathrm{mEq/L}$, total calcium $8.5\text{–}10.5\ \mathrm{mg/dL}$, magnesium $1.7\text{–}2.4\ \mathrm{mg/dL}$, and phosphate $2.5\text{–}4.5\ \mathrm{mg/dL}$. These ranges vary by laboratory and should be interpreted alongside symptoms, kidney function, medications, and related results.

A useful way to organize assessment is to ask three questions: Is the patient in immediate danger? What mechanism could explain the result? Which related values or clinical changes need monitoring?

Sodium and Water Balance

Sodium is the principal extracellular cation and helps determine extracellular fluid osmolality and volume. Serum sodium chiefly reflects the balance between body water and exchangeable sodium and potassium, so abnormal sodium concentration is often primarily a water-balance problem. Thirst, antidiuretic hormone (ADH), and kidney handling of water all contribute to regulation.

Low sodium

Hyponatremia is a serum sodium below $135\ \mathrm{mEq/L}$. Common causes include excess water relative to sodium, as in SIADH, heart failure, cirrhosis, thiazide use, or administration of hypotonic fluid. Vomiting and diarrhea can also contribute through sodium and water losses. Volume status, serum osmolality, urine osmolality, and urine sodium can help clarify the cause.

Symptoms are mainly neurologic because water may move into brain cells. Gradual or mild changes may cause nausea, headache, or impaired attention. A rapid or severe decline can lead to confusion, seizures, coma, or respiratory compromise. Treatment depends on the cause and volume status. It may include treating the underlying condition, restricting fluid, or giving isotonic saline when volume depleted. Severe, acute, or strongly symptomatic cases may require carefully monitored hypertonic saline. Sodium must not be raised too quickly: overly rapid correction can cause osmotic demyelination. Many adults are corrected by no more than about $8\ \mathrm{mEq/L}$ in $24$ hours, although individual targets depend on risk and clinical guidance.

High sodium

Hypernatremia is a serum sodium above $145\ \mathrm{mEq/L}$ and usually indicates a water deficit relative to sodium. Causes include limited access to water, impaired thirst, gastrointestinal or skin water losses, and impaired ADH production or response. Thirst, restlessness, weakness, and irritability may progress to confusion, seizures, or coma.

If shock or significant volume depletion is present, circulation is restored first. Free water is then replaced orally or intravenously as appropriate. Chronic or unknown-duration hypernatremia is generally corrected gradually, because a rapid reduction can cause cerebral edema. The plan depends on duration, symptoms, volume status, and ongoing losses.

Takeaway: Sodium abnormalities are closely tied to water balance. The severity of symptoms and the speed and safety of correction matter as much as the laboratory value.

Potassium and Cardiac Conduction

Potassium is the principal intracellular cation. Its small extracellular fraction is essential for resting membrane potential, muscle function, and cardiac conduction. The kidneys regulate potassium excretion, and aldosterone promotes renal potassium loss. Insulin and beta-adrenergic stimulation shift potassium into cells; acid–base changes and cell injury can also shift it between compartments. As a result, serum potassium can change without a matching change in total-body potassium.

Low potassium

Hypokalemia is a serum potassium below $3.5\ \mathrm{mEq/L}$. Causes include diuretics, vomiting, diarrhea, renal losses, inadequate intake, and shifts into cells, such as after insulin. Symptoms can include weakness, cramps, constipation, or ileus. Severe deficiency can cause respiratory weakness and dangerous arrhythmias. ECG changes may include flattened T waves and prominent U waves.

Potassium replacement should address both the deficit and its cause. Oral replacement is generally preferred when the patient can take it and the situation is not an emergency. Intravenous replacement is reserved for severe or symptomatic deficiency, or when oral treatment is not feasible. It must be diluted and infused at a controlled rate: never give potassium by IV push. Check renal function and repeat potassium levels; use ECG monitoring when indicated and account for ongoing losses. Correct magnesium deficiency as well, because it can make potassium difficult to restore.

High potassium

Hyperkalemia is commonly defined as serum potassium above $5.5\ \mathrm{mEq/L}$, although laboratory cutoffs vary. Causes include impaired renal excretion, potassium-retaining medications, adrenal insufficiency, and potassium release from injured cells. Hemolysis can produce pseudohyperkalemia. If an unexpected result occurs in a stable patient, repeat a carefully collected sample promptly; do not delay urgent assessment when severe hyperkalemia is plausible.

Hyperkalemia may have no symptoms until cardiac conduction is affected. ECG changes can include peaked T waves, PR prolongation, and QRS widening, with progression to lethal arrhythmias. Emergency treatment may include IV calcium to stabilize cardiac membranes, therapies that shift potassium into cells, and measures to remove potassium from the body. Calcium does not lower serum potassium; it temporarily reduces cardiac toxicity. Recheck potassium and glucose as appropriate, since shifting treatments are temporary and insulin can cause hypoglycemia.

Takeaway: Potassium disturbances can threaten cardiac conduction. Confirm unexpected results when appropriate, assess the ECG and kidney function, and use monitored, controlled treatment.

Calcium: Active Forms and Clinical Effects

Calcium supports nerve and muscle function, cardiac contraction, blood coagulation, and bone structure. Parathyroid hormone (PTH), active vitamin D (calcitriol), the kidneys, intestines, and bone coordinate calcium balance. PTH raises serum calcium and increases renal phosphate excretion; vitamin D increases intestinal absorption of calcium and phosphate.

Much circulating calcium is bound to albumin, while ionized calcium is the biologically active form. Low albumin can lower total calcium without lowering ionized calcium. Alkalosis can also reduce ionized calcium by increasing protein binding. Measure ionized calcium when the total value may be misleading or symptoms do not fit the result.

Low calcium

Hypocalcemia may result from hypoparathyroidism, vitamin D deficiency, kidney disease, magnesium deficiency, pancreatitis, or phosphate excess. It increases neuromuscular excitability and may cause tingling around the mouth or in the fingers, cramps, hyperreflexia, or tetany. Severe deficiency can cause seizures, laryngospasm, and cardiac effects such as QT prolongation.

Assessment may include ionized calcium, magnesium, phosphate, renal function, PTH, and vitamin D. Acute symptomatic cases may require IV calcium with cardiac monitoring; less acute cases are often treated with oral calcium and management of the cause. Correct magnesium deficiency when present, since it can impair PTH release and action and make hypocalcemia persistent. Use caution with IV calcium, especially with digoxin use or significant hyperphosphatemia, and monitor for tissue injury if IV access is compromised.

High calcium

Hypercalcemia is commonly caused by primary hyperparathyroidism or malignancy. Other causes include some medications, vitamin D excess, and prolonged immobility. Symptoms can include constipation, nausea, abdominal discomfort, polyuria, thirst, weakness, and confusion. Severe cases can alter consciousness, injure the kidneys, or cause cardiac abnormalities.

Verify the result, assess hydration and kidney function, and investigate the cause; PTH is a key initial discriminator. Treatment addresses the underlying disorder. Clinically significant cases often require IV fluids and may need medications that reduce bone resorption or other targeted therapy. Monitor fluid status and renal function, particularly in people with heart or kidney disease. Avoid unsupervised calcium or vitamin D supplements while the cause is being evaluated.

Takeaway: Total calcium can be misleading, so connect symptoms with ionized calcium and consider the linked roles of magnesium, phosphate, PTH, and vitamin D.

Magnesium, Phosphate, and Linked Imbalances

Magnesium

Magnesium is stored mainly in bone and inside cells, so serum concentration does not perfectly reflect total-body stores. It supports enzyme activity, nerve and muscle function, and cardiac rhythm, and helps regulate potassium and calcium transport. Gastrointestinal losses, poor intake, alcohol use disorder, and some medications can lower magnesium. Kidney impairment and magnesium-containing antacids or laxatives can contribute to excess.

Hypomagnesemia may cause tremor, weakness, hyperreflexia, cramps, tetany, seizures, or arrhythmias. It often accompanies hypokalemia or hypocalcemia and can make either difficult to correct. Many mild cases are treated with oral magnesium; severe symptoms or inability to take oral treatment may call for IV replacement. Monitor closely when kidney function is reduced because magnesium can accumulate, and assess potassium and calcium as well.

High magnesium is most likely when impaired renal excretion occurs alongside magnesium-containing products. Toxicity may progress from nausea, flushing, and lethargy to diminished deep-tendon reflexes, hypotension, bradycardia, respiratory depression, and cardiac arrest. Stop magnesium sources and assess breathing, hemodynamic status, and cardiac function. Severe toxicity may require IV calcium as an antagonist and, in selected cases, diuresis or dialysis.

Phosphate

Phosphate is essential for ATP energy transfer, cell membranes, nucleic acids, bone mineralization, and intracellular buffering. It is stored mainly in bone and cells. The kidneys regulate phosphate excretion; PTH and fibroblast growth factor 23 (FGF23) increase urinary phosphate loss, while vitamin D increases intestinal absorption. Calcium and phosphate balance are linked, and substantial phosphate abnormalities can alter calcium availability.

Hypophosphatemia may result from poor intake or absorption, increased renal loss, or movement into cells. Refeeding after prolonged malnutrition, insulin treatment, and recovery from diabetic ketoacidosis can precipitate a shift into cells. Severe deficiency can impair ATP-dependent function, causing profound weakness, respiratory muscle dysfunction, confusion, seizures, or cardiac dysfunction. Treatment addresses the cause, with replacement guided by severity, symptoms, kidney function, and ability to take oral medication. IV replacement is reserved for selected severe cases and requires monitoring: levels can fall again with continued shifts, while replacement can cause hypocalcemia, hyperkalemia, or calcium-phosphate deposition.

Hyperphosphatemia most often reflects reduced kidney excretion, particularly in advanced kidney disease. Other causes include cell breakdown, phosphate-containing bowel preparations or laxatives, and reduced PTH action. Patients may have no direct symptoms, but phosphate can lower ionized calcium and cause tingling, cramps, or tetany. Chronic elevation in kidney disease can contribute to soft-tissue and vascular calcification. Treatment addresses the cause; in chronic kidney disease, follow the renal care plan for dietary phosphate and prescribed binders, which are taken with meals. Avoid unnecessary phosphate-containing laxatives or enemas, especially in kidney disease.

Takeaway: Magnesium and phosphate disturbances can affect calcium and potassium. When treating an abnormality, monitor related electrolytes and kidney function, not just the value being replaced.

Assessment and Safe Correction

When an electrolyte result is abnormal, use a consistent sequence:

1. Assess the patient first. Check mental status, vital signs, neuromuscular findings, breathing, fluid balance, and ECG when indicated. Seizure, altered consciousness, respiratory compromise, hypotension, or a new arrhythmia requires urgent escalation.

2. Confirm and contextualize the result. Review prior values, sample quality, laboratory reference ranges, kidney function, glucose, acid–base status, medications, intake, and ongoing losses. Consider ionized rather than total calcium when appropriate.

3. Look for linked abnormalities. Examples include magnesium deficiency with potassium or calcium that is difficult to correct, and phosphate excess with low calcium.

4. Correct the cause and recheck. Replacement or fluid therapy can overshoot, cause a dangerous shift, or fail if losses continue. Individualize route, rate, monitoring frequency, and target. Severe abnormalities require clinician-directed protocols.

The central principle is to treat the patient and the cause, not just the laboratory number. Symptoms, time course, kidney function, fluid status, medications, and related electrolytes help guide a safe plan.